Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
Teva Pharmaceutical Industries will establish production of its injectable drugs in Russia, at the facilities of the local Nanolek enterprise. 17 October 2016
Generics
Prices for cheap drugs from the list of vital medicines may significantly increase in Russia this year due to a recent decision by the Russian government to refrain from further state regulation of prices for drugs from this segment. 17 October 2016
Pharmaceutical
National Immunobiologicheskaja Company (Natsimbio), one of Russia’s largest vaccines producers that is part of the local state corporation Rostec, has announced plans to launch the production of a vaccine for the prevention of pneumococcal disease during the next several years, The Pharma Letter’s local correspondent reports. 6 October 2016
Pharmaceutical
All the drugs presenting on the Russian market will have to be labeled by a QR-code with the aim of preventing counterfeiting, according to recent statements of Denis Manturov, Russia’s Minister of Industry and Trade, reports The Pharma Letter’s local correspondent. 6 October 2016
Pharmaceutical
The Russian Federal Antimonopoly Service (FAS) may cancel registration of certain imported drugs, which are presented in the Russian market, due to the pricing policy, which is implemented by their producers, according to an official spokesman for the agency, reports The Pharma Letter’s local correspondent. 30 September 2016
Generics
As a major member of Fosun Pharma family, Chongqing-based Yao Pharma is a key part of Fosun Pharma’s global strategy. 22 September 2016
Biosimilars
Much like its parent company Fosun Group, China’s Fosun Pharma also likes to shop. 21 September 2016
Generics
Some more essential drugs to treat cancer, malaria and epilepsy have been brought under price revision and, in certain cases, price control by the Indian government. The move has not gone down well with pharmaceutical companies, reports The Pharma Letter’s India correspondent. 21 September 2016
Pharmaceutical
The Russian Ministry of Health is changing the existing procedure for the launch of new drugs on the domestic market, with the aim to speed their withdrawal, according to recent statements by Veronika Skvortsova, Russia’s Minister of Health, reports The Pharma Letter’s local correspondent. 21 September 2016
Pharmaceutical
The Russian Ministry of Health is considering changing the conditions of tendering for the public procurement of high-priced drugs and vaccines, according to recent statements of an official spokesman of Veronika Skvortsova, Russia’s Minister of Health. 15 September 2016
Pharmaceutical
In India, 33 drugs supplied to various government hospitals and stores in Arunachal Pradesh were found to be of sub-standard quality during laboratory tests. 30 August 2016
Pharmaceutical
The Russian Federal Anti-Monopoly Service (FAS) has started investigations regarding the recent detection of a cartel in the Russian pharmaceutical market, which was created by some leading local drugmakers and global majors operating in the Russian market, according to press-service of the FAS, reports The Pharma Letter’s local correspondent. 26 August 2016
Pharmaceutical
The Ministry of Health of Ukraine has officially approved the conduct of clinical trials of drugs imported to the country – the initiative that has long been lobbied by global pharmaceutical majors, operating in the country. 26 August 2016
Pharmaceutical
Russian President Vladimir Putin has instructed the national Federal Anti-Monopoly Service (FAS) and the federal government to continue regular monitoring of drug prices in the domestic market, as well as their compliance with the current market realities. 8 August 2016
Pharmaceutical
GlaxoSmithKline may consider the possibility of filing a petition to the Russian court with the complaint on the conditions of the forthcoming tender for the purchases of anti-pneumococcal vaccines for state needs in Russia. 1 August 2016
Pharmaceutical
The Russian government is considering providing support to the domestic pharmaceutical producers planning to export their drugs, according to recent statements by Russia’s Prime-Minister Dmitry Medvedev, reports The Pharma Letter’s local correspondent. 1 August 2016
Pharmaceutical
Even as a battle royal continues between Teva Pharmaceutical Industries (NYSE: TEVA) and Merck & C0 (NYSEL MRK) over the former’s alleged infringement of the latter’s Januvia (sitagliptin) patent in India, the recent decision of the Indian Patent Office to deny Cipla's patent application for an anti retroviral combination reveals its unbiased nature, reports The Pharma Letter’s India correspondent. 31 July 2016
Pharmaceutical
Sales of mid- and high-priced drugs in Russia are steadily declining, due to the ongoing economic stagnation in the country and the consequences of the financial crisis, reports The Pharma Letter’s local correspondent. 21 July 2016
Pharmaceutical
US drugmaker Abbott is considering further expanding of its Russian business during the next several years, according to recent statements of Michael Vormut, Abbott’s executive vice-president. 21 July 2016
Pharmaceutical
The Russian government is considering introducing a three-stage procedure for the public procurement of drugs, according to recent statements of an official spokesman of Denis Manturov, Russia’s Minister of Industry and Trade. 12 July 2016
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Generics
Indian drugmaker Aurobindo Pharma has taken on the might of China in terms of Penicillin G pricing, and is doing so by leveraging a fully integrated production process at its new plant. Anticipating the price erosion of Penicillin G, the company has put up an integrated plant from scratch. 10 November 2024
Generics
Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new opportunities for India, especially in the pharmaceutical sector. 8 November 2024
Biotechnology
According to UNICEF's State of the World's Children 2023 report, in Latin America
and the Caribbean, 6.8 million children did not benefit from vaccination during the
time of the pandemic and in the following two years, progress has not been as
expected either. 7 November 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step towards consolidating and advancing the country's biotechnology initiative. 7 October 2024
Pharmaceutical
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Generics
The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall reduction of investment activities in the local pharmaceutical market, reports The Pharma Letter’s local correspondent. 30 September 2024
Pharmaceutical
Pharmaceutical laboratories, institutions, guilds and medical federations have taken on the task of designing programs to end health illiteracy in order to have informed, educated, knowledgeable and empowered communities where their health and wellbeing are concerned. 19 September 2024
Pharmaceutical
Oligonucleotide therapeutics are rapidly emerging as a promising class of drugs capable of addressing a variety of genetic and complex diseases by targeting RNA sequences.1 16 September 2024
Generics
The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, according to recent statements by Konstantin Panurovsky, legal director of AstraZeneca’s Russian subsidiary, reports The Pharma Letter’s local correspondent. 13 September 2024
Pharmaceutical
The Russian Ministry of Health wants to speed registration of drugs that are not localized in the Russian Federation at the time of the application submitted by domestic pharmaceutical companies, explaining such changes by "unpredictable geopolitical situation," reports The Pharma Letter’s local correspondent. 12 September 2024
Biotechnology
NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s 11 September 2024
Generics
A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 9 September 2024
Biotechnology
Targeted alpha therapy (TAT), or radioligand therapy, is a recent hot area that attracted big pharmas like Bristol Myers Squibb and Novartis. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Pharmaceutical
Scientists from the Russian Institute of Immunology of the Federal Medical and Biological Agency (FMBA) say they have created the world's first allergy vaccine. 30 August 2024
Generics
In a major crackdown, the Indian government has imposed an immediate ban on 156 fixed-dose combination (FDC) drugs, including commonly used antibiotics, pain relievers,and multivitamins. 27 August 2024
Pharmaceutical
Russia plans to create conditions for a significant increase of domestic production of anti-Rhesus immunoglobulin drugs after a sharp decrease of their imports to the local market this year, reports The Pharma Letter’s local correspondent. 22 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze